+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Biosimilar Interleukins Market Report 2025 - Product Thumbnail Image

Biosimilar Interleukins Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Therapeutic Peptides Market Report 2025 - Product Thumbnail Image

Biosimilar Therapeutic Peptides Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Oncology Biosimilars Market Report 2025 - Product Thumbnail Image

Oncology Biosimilars Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
Biosimilars Market Report 2025 - Product Thumbnail Image

Biosimilars Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Lung Cancer Drugs Market Report 2025 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Market Report 2025 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
US Biosimilar Market: Insights & Forecast (2024-2028) - Product Thumbnail Image

US Biosimilar Market: Insights & Forecast (2024-2028)

  • Report
  • August 2024
  • 72 Pages
  • United States
From
From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Loading Indicator